Glycopyrronium Bromide inhaler

BNF:

3.1

Status:

Grey

Decision Date:

June 2015

Comments

GREY 2nd line LAMA:^1,2

• Seebri Breezhaler and caps (DPI) (Decision date - August 19)

Brown Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy
• 2: Lack of data on safety compared with standard therapy

search again